Dynavax Technologies
DVAX
#5489
Rank
S$1.66 B
Marketcap
S$14.17
Share price
-0.18%
Change (1 day)
-18.16%
Change (1 year)

Dynavax Technologies (DVAX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$0.53 Billion

According to Dynavax Technologies 's latest financial reports the company's total liabilities are S$0.53 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Dynavax Technologies - Total liabilities on balance sheet (from 2003 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$0.52 B6.88%
2023-12-31S$0.49 B-8.74%
2022-12-31S$0.54 B-50.86%
2021-12-31S$1.10 B183.37%
2020-12-31S$0.38 B6.75%
2019-12-31S$0.36 B80.77%
2018-12-31S$0.20 B684.91%
2017-12-31S$25.72 M-13.2%
2016-12-31S$29.63 M-29.1%
2015-12-31S$41.8 M-16.32%
2014-12-31S$49.95 M115.14%
2013-12-31S$23.22 M-23.82%
2012-12-31S$30.48 M-31.22%
2011-12-31S$44.31 M7.06%
2010-12-31S$41.39 M-33.13%
2009-12-31S$61.9 M-41.87%
2008-12-31S$0.10 B-8.99%
2007-12-31S$0.11 B220.4%
2006-12-31S$36.52 M282.82%
2005-12-31S$9.54 M-57.53%
2004-12-31S$22.46 M-85.11%
2003-12-31S$0.15 B-1.04%
2002-12-31S$0.15 B66.23%
2001-12-31S$91.69 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Agenus
AGEN
S$0.66 B 24.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$14.25 B 2,567.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$100.59 B 18,727.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$48.03 B 8,891.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$88.73 B 16,507.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
S$79.40 B 14,761.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
S$149.82 B 27,941.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$42.24 B 7,806.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
S$104.32 B 19,426.73%๐Ÿ‡บ๐Ÿ‡ธ USA